Astellas Pharma Total Assets 2012-2019 | ALPMY

Astellas Pharma total assets from 2012 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Astellas Pharma total assets for the quarter ending June 30, 2019 were $17.536B, a 11.33% increase year-over-year.
  • Astellas Pharma total assets for 2019 were $0B, a 100% decline from 2018.
  • Astellas Pharma total assets for 2018 were $17.53B, a 7.82% increase from 2017.
  • Astellas Pharma total assets for 2017 were $16.258B, a 8.86% increase from 2016.
Astellas Pharma Annual Total Assets
(Millions of US $)
2019 $0
2018 $17,530
2017 $16,258
2016 $14,935
2015 $16,322
2014 $16,050
2013 $15,378
2012 $17,081
2011 $0
2010 $0
2009 $0
2008 $0
2007 $0
2006 $0
Astellas Pharma Quarterly Total Assets
(Millions of US $)
Q1 2019 $17,536
Q1 2018 $17,172
Q1 2017 $17,111
Q2 2016 $16,789
Q1 2016 $15,751
Q4 2016 $14,935
Q3 2015 $14,660
Q2 2015 $14,520
Q1 2015 $14,596
Q4 2015 $16,322
Q3 2014 $16,296
Q2 2014 $16,467
Q1 2014 $15,840
Q4 2014 $16,050
Q3 2013 $15,652
Q2 2013 $15,121
Q1 2013 $14,858
Q4 2013 $15,378
Q3 2012 $17,442
Q2 2012 $16,758
Q1 2012 $16,702
Q4 2012 $17,081
Q3 2011 $17,529
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $29.466B $11.834B
Astellas Pharma, Inc. is engaged in the research, development, manufacturing and marketing of pharmaceuticals drugs. Products offered by the Company include Prograf applicable for the prevention of rejection in organ transplants, Vesicare for treatment of overactive bladder, Protopic for the treatment of atopic dermatitis in the topical immunomodulator class, Harnal to treat the functional symptoms of benign prostatic hyperplasia (BPH), including weak urinary stream, frequent nighttime urination, and sensation of incomplete emptying of the bladder and Fungard an antifungal agent. Astellas Pharma, Inc. is headquartered in Tokyo, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $63.617B 36.80
Takeda Pharmaceutical (TAK) Japan $54.955B 9.74
Eisai (ESALY) Japan $21.073B 40.62
UCB SA (UCBJF) Belgium $18.905B 0.00
Grifols, S.A (GRFS) Spain $16.144B 21.15
Merck (MKGAF) Germany $15.852B 21.63
Ono Pharmaceutical (OPHLF) Japan $11.311B 24.18
Neurocrine Biosciences (NBIX) United States $8.486B 235.77
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Catalent (CTLT) United States $7.680B 31.60
Ionis Pharmaceuticals (IONS) United States $7.496B 22.49
Jazz Pharmaceuticals (JAZZ) Ireland $6.349B 7.74
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.877B 0.00
Orion OYJ (ORINY) Finland $5.871B 30.12
IPSEN SA ADR (IPSEY) France $5.641B 0.00
STADA ARZNEIMI (STDAF) Germany $5.543B 0.00
Hypermarcas (HYPMY) Brazil $4.584B 13.94
United Therapeutics (UTHR) United States $4.423B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.660B 67.93
Evotec AG (EVTCY) Germany $3.643B 58.78
Nektar Therapeutics (NKTR) United States $3.612B 0.00
FibroGen (FGEN) United States $3.539B 104.00
PTC Therapeutics (PTCT) United States $3.300B 0.00
Sage Therapeutics (SAGE) United States $2.695B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.675B 10.82
ChemoCentryx (CCXI) United States $2.565B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.955B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.883B 22.89
Xencor (XNCR) United States $1.833B 74.86
Pacira Pharmaceuticals (PCRX) United States $1.800B 49.22
Heron Therapeutics (HRTX) United States $1.615B 0.00
Corcept Therapeutics (CORT) United States $1.529B 17.10
Tilray (TLRY) Canada $1.461B 0.00
Esperion Therapeutics (ESPR) United States $1.429B 0.00
USANA Health Sciences (USNA) United States $1.402B 14.72
CLINIGEN GP (CLIGF) United Kingdom $1.392B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.358B 0.00
Endo (ENDP) Ireland $1.277B 2.36
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.134B 15.79
Zogenix (ZGNX) United States $1.048B 0.00
Karyopharm Therapeutics (KPTI) United States $1.008B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.993B 30.75
Akebia Therapeutics (AKBA) United States $0.987B 0.00
Radius Health (RDUS) United States $0.911B 0.00
Portola Pharmaceuticals (PTLA) United States $0.791B 0.00
Aerie Pharmaceuticals (AERI) United States $0.790B 0.00
Collegium Pharmaceutical (COLL) United States $0.727B 0.00
ImmunoGen (IMGN) United States $0.657B 0.00
Flexion Therapeutics (FLXN) United States $0.592B 0.00
Molecular Templates (MTEM) United States $0.579B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.511B 0.00
TherapeuticsMD (TXMD) United States $0.451B 0.00
Ardelyx (ARDX) United States $0.440B 0.00
Translate Bio (TBIO) United States $0.435B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.431B 52.25
BioSpecifics Technologies Corp (BSTC) United States $0.426B 18.35
Innate Pharma SA (IPHYF) France $0.423B 0.00
Indivior (INVVY) United States $0.417B 2.48
BioCryst Pharmaceuticals (BCRX) United States $0.407B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.382B 0.00
Siga Technologies (SIGA) United States $0.375B 8.57
Organogenesis Holdings (ORGO) United States $0.370B 0.00
Calithera Biosciences (CALA) United States $0.357B 0.00
Lannett Co Inc (LCI) United States $0.353B 5.69
Harpoon Therapeutics (HARP) United States $0.350B 0.00
DURECT (DRRX) United States $0.342B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.342B 0.00
Recro Pharma (REPH) United States $0.337B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.326B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.314B 0.00
Rafael Holdings (RFL) United States $0.311B 0.00
Concert Pharmaceuticals (CNCE) United States $0.301B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.271B 0.00
OptiNose (OPTN) United States $0.268B 0.00
KalVista Pharmaceuticals (KALV) United States $0.239B 0.00
Ocular Therapeutix (OCUL) United States $0.221B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.217B 0.00
MEI Pharma (MEIP) United States $0.212B 0.00
Taiwan Liposome (TLC) Taiwan $0.185B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.183B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.183B 0.00
Nature's Sunshine Products (NATR) United States $0.178B 30.73
Matinas Biopharma Holdings (MTNB) United States $0.169B 0.00
Jounce Therapeutics (JNCE) United States $0.151B 2.79
IMV INC (IMV) Canada $0.122B 0.00
VAXART, INC (VXRT) United States $0.118B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.114B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.110B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.103B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.098B 0.00
Xeris Pharmaceuticals (XERS) United States $0.097B 0.00
CannTrust Holdings (CTST) Canada $0.095B 0.00
Otonomy (OTIC) United States $0.093B 0.00
Aquestive Therapeutics (AQST) United States $0.089B 0.00
Redhill Biopharma (RDHL) Israel $0.089B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.085B 0.00
Generex Biotechnology (GNBT) United States $0.082B 0.00
Neos Therapeutics (NEOS) United States $0.077B 0.00
Champions Oncology (CSBR) United States $0.075B 0.00
Infinity Pharmaceuticals (INFI) United States $0.069B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.069B 0.00
Onconova Therapeutics (ONTX) United States $0.065B 0.00
MediWound (MDWD) Israel $0.065B 0.00
CV Sciences (CVSI) United States $0.065B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.062B 18.64
RENEURON GP (RNUGF) United Kingdom $0.061B 0.00
Nivalis Therapeutics (ALPN) United States $0.059B 0.00
CTI BioPharma (CTIC) United States $0.058B 0.00
SCYNEXIS (SCYX) United States $0.056B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.052B 0.00
IsoRay (ISR) United States $0.052B 0.00
Natural Alternatives (NAII) United States $0.051B 23.13
AgeX Therapeutics (AGE) United States $0.048B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.048B 0.00
Aclaris Therapeutics (ACRS) United States $0.047B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.045B 0.00
Forward Pharma (FWP) Denmark $0.043B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.037B 0.00
PolarityTE (PTE) United States $0.037B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.032B 0.00
Jaguar Animal Health (JAGX) United States $0.030B 0.00
China SXT Pharmaceuticals (SXTC) China $0.028B 0.00
Biomerica (BMRA) United States $0.027B 0.00
PharmAthene (ALT) United States $0.027B 0.00
ElectroCore (ECOR) United States $0.023B 0.00
Vical (BBI) United States $0.022B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.022B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
India Globalization Capital (IGC) United States $0.019B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Cardiome Pharma (CORV) Canada $0.017B 0.00
Shineco (TYHT) China $0.017B 0.00
Bio-Path Holdings (BPTH) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.016B 0.00
Hemispherx BioPharma (AIM) United States $0.014B 0.00
Lipocine (LPCN) United States $0.013B 0.00
Heat Biologics (HTBX) United States $0.012B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.012B 0.00
HANCOCK JAFFE (HJLI) United States $0.012B 0.00
Novan (NOVN) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.007B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.006B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
RXi Pharmaceuticals (PHIO) United States $0.002B 0.00
Can-Fite Biopharma (CANF) Israel $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00